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A B S T R A C T
Fabry disease is an X-linked recessive glycolipid storage disease. It is caused by deficiency of the lysosomal enzyme
a-galactosidase A and leads to the accumulation of the enzyme substrate, globotriasylceramide (Gb3) in many tissues in-
cluding endothelial cells, pericytes and smooth muscle cells of blood vessels, renal epithelial cells, cardiac myocytes and
numerous neuronal cells. In this report, we present 20-year-old male patient with ischemic stroke in pons. The case had
previously been misdiagnosed as polimyositis and vasculitis. Angiokeratomas, neuropathic pain and ischemic stroke in
young age suggested a Fabry disease. The diagnosis was confirmed biochemically and genetically. All young adults with
stroke, especially if they have additional symptoms like angiokeratomas, proteinuria, neuropathic pain in toes and fin-
gers should be tested for Fabry disease.
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Introduction
Fabry disease is an X-linked recessive glycolipid stor-
age disease, caused by the deficiency of the lysosomal en-
zyme a-galactosidase A that leads to the accumulation of
the enzyme substrate, globotriasylceramide (Gb3) in many
tissues including endothelial cells, pericytes and smooth
muscle cells of blood vessels, renal epithelial cells, car-
diac myocytes and numerous neuronal cells1. Fabry dis-
ease usually presents in childhood with acroprasthesia
(constant burning pain) especially in the toes and fin-
gers, and with painful crises, during which there are ex-
tremely severe attacks of sharp pain. The disease usually
causes death in adult life from renal, cardiac or cere-
brovascular complications of vascular disease. Stroke is a
major cause of mortality and morbidity in patients with
Fabry diseases2. The most common cerebrovascular dis-
order in patients with FD is ischemic stroke involving
infarctions in the vertebrobasilar territory3,4. The possi-
ble etiologies of ischemic stroke affecting essentially the
posterior circulation are progressive stenosis of small
vessels with Gb3 deposits, arterial remodeling, endothe-
lial dysfunction, pro-thrombotic state, cerebral hypoper-
fusion consecutive to dysautonaumy and cardiac embo-
lism4. Fabry disease may be misdiagnosed with different
diseases including multiple sclerosis, vasculitis5,6. In this
case report, we aimed to evaluate diagnostic difficulties
and treatment modalities in a patient with FD who had
an initially misdiagnosed of vasculitis.
Case Report
In February 2008 a 21-year-old male was referred to
our hospital for neurological evaluation, two months af-
ter he had ischemic stroke of undetermined etiology. In
childhood he had a frequent neuropathic pain in hands
and legs, especially when he had fever or after exercise.
In 2005, he had diplopia and vertigo which spontane-
ously resolved in 15 days. Hyperintensive lesions, deep in
white matter, predominantly frontaly left had been ob-
served in cerebral magnetic resonance imaging (MRI) ex-
amination.
The case had been diagnosed as Raynaud syndroma.
The entire time patient had neuropathic pains. In the
mean time, because of constant pain, muscle biopsy had
been done. According to result of muscle biopsy, diagno-
sis of neurogenic myopathy had been established.
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In 2007, he had right hemiparesis and dysarrthrya.
MRI pointed out ischemic lesion in pons. Extensive car-
diac, arterial and hematologic investigations did not iden-
tify the etiology of his stroke. Although all laboratory
tests for vasculitis were negative, except high CRP which
was 77, the diagnosis of vasculitis had been established.
He had been treated with high dose of corticosteroids
and anticoagulant therapy.
In February 2008 he had been hospitalized at Depart-
ment of Neurology. His neurological examination re-
vealed normal mental status, residual right hemiparesis
and difficulty in tandem walk. He had multiple red-pur-
ple papules, symmetrically distributed on the lower back.
Clinical, medical record and radiological findings sug-
gested Fabry disease. The diagnosis was confirmed bio-
chemically by the absence of a-galactosidase A enzime
activity (0 nmol/L normal 4-22 nmol/L). No cardiac, kid-
ney or ophthalmologic involvements were defined.
The genetic analysis was performed in Rostock and
pointed out GLA mutation in the DNA-sample with dele-
tion c.115_132delACGCCTACCATGGG. This mutation
is so far not described in literature, but results in a
frameshift that causes a different protein sequence.
Family tree includes mother, father, 4 sisters and 1
brother and 18 relatives had been tested for Fabry dis-
ease, but all were negative. The patient is under agali-
sidase beta to replace a-galactosidase A enzyme for 10
months with a dose of 1 mg/kg (totally 70 mg) once every
2 weeks. The patient still has pain in legs and palms, but
with lower intensity than before.
Discussion
In this case report, we present a patient with FD who
was misdiagnosed for many years. His first symptoms
were neuropathic pains, but it was misdiagnosed and
treated for Raynaud syndrome.
After some years, when the changes of white matter
in brain were seen on MRI, poliomyositis was diagnosed.
He was treated with corticosteroids. In the age of 20
years he had ischemic stroke in pons, but again he was
misdiagnosed, this time with vasculitis. All parameters
for vasculitis were negative, excepted high sedimentation
rate.
He came to our hospital for second opinion. Clinical
picture which include angiokeratomas, neuropathic pain
and stroke in young adults suggested Fabry disease.
The diagnosis was confirmed biochemically and ge-
netically. His complete family was tested biochemically
and genetically but all were negative. So we can conclude
that this patient has a new mutation of enzyme a-galac-
tosidase A. Fabry disease may mimic various neurologi-
cal diseases such as demyelinating disease, neuropathies,
and stroke.
In the literature, some case reports about misdiag-
nose of FD with multiple sclerosis were reported.
Unfortunately, in this case, the FD was misdiagnosing
with poliomyositis and vasculitis and the patients had
been treating with corticosteroids. Fabry disease must be
considered in all cases of unexplained stroke in young pa-
tients, especially in cases with the combination of infarc-
tion in the vertebrobasilar artery system and protei-
nuria6-9. Fabry disease usually presents in childhood with
acroparasthesia (constant burning pain) especially in the
toes and fingers, and with painful crises, during which
there are extremely severe attacks of sharp pain.
All children with unexplained neuropathic pain in
toes and fingers especially with additional signs have to
be checked for a-galactosidase enzyme activity. There is
no cure for Fabry disease. Treatment with recombinant
alpha-Gal A is available and should be considered for eli-
gible individuals. Two formulations of recombinant hu-
man alpha-Gal A have been developed, agalsidase alpha
and agalsidase beta.
Although there is no clear evidence of the benefit of
enzyme replacement therapy in patients with cerebro-
vascular events, several studies have shown that such
treatment does have an effect on resting cerebral blood
flow abnormalities10.
Further studies are required to determine whether
enzyme replacement treatment in Fabry disease will re-
sult in a reduction in clinical outcomes such as stroke,
ischemic heart disease and end-stage renal disease.
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NERUOLO[KE MANIFESTACIJE FABRYEVE BOLESTI – PRIKAZ SLU^AJA
S A @ E T A K
Fabryeva bolest je X-vezani recesivni poreme}aj nakupljanja glikolipida. Uzrokuje ju nedostatak lizosomskog en-
zima a-galaktozidaze A, koji dovodi do nakupljanja supstrata, globotriasilceramida (Gb3) u mnogim tkivima koja uklju-
~uju endotel, pericite i glatke mi{i}e krvnih `ila, stanice bubre`nog epitela, sr~ani mi{i} i mnoge neurone. U ovom
prikazu slu~aja prikazan je mu{ki pacijent starosti 20 godina, koji je primljen zbog ishemi~nog mo`danog udara u
podru~ju ponsa. Prije ove epizode, pacijent je bio pogre{no dijagnosticiran kao polimiozitis i vaskulitis. Pojava angio-
keratoma, neuropatske boli i ishemi~nog mo`danog udara kod mladog pacijenta ukazala je na Fabryevu bolest. Dija-
gnoza je potvr|ena biokemijski i genetski. Svi mladi pacijenti s mo`danim udarom, posebno ako imaju dodatne sim-
ptome poput angiokeratoma, proteinurije, neuropatske boli no`nih prstiju i prstiju ruke trebali bi biti testirani na
Fabryevu bolest.
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